Leishmaniasis

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leishmaniasis.php on line 2
Leishmaniasis

LE WE PMID CA

Leishmaniasis

1572

Leishmaniasis

Aids

Anaplasma phagocytophilicum

Bartonella spp

Borreliosis

Chagas disease

Ehrlichiosis

Home pet

Infection control and surveillance

Leishmaniasis

Malaria

Methylglyoxal

Microsporidiosis

Neutrophils

Parasites

Rickettsia

Trypanosomiasis Sleeping disease

2003 1	Leishmaniasis: new approaches to disease control. [12586674] BMJ 326(7385): 377-82 (2003)
1998 2	Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. [9487211] Arch Dermatol 134(2): 193-8 (1998)
2005 3	Cutaneous leishmaniasis in Pakistan. [15748545] Dermatol Online J 11(1): 4 (2005)
2001 4	Clinical and experimental advances in treatment of visceral leishmaniasis. [11451673] Antimicrob Agents Chemother 45(8): 2185-97 (2001)
1988 5	Biochemistry of the Leishmania species. [3070318] Microbiol Rev 52(4): 412-32 (1988)
2006 6	Drug resistance in leishmaniasis. [16418526] Clin Microbiol Rev 19(1): 111-26 (2006)
2005 7	Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. [15831826] Clin Microbiol Rev 18(2): 293-305 (2005)
1993 8	Leishmaniases of the New World: current concepts and implications for future research. [8358705] Clin Microbiol Rev 6(3): 230-50 (1993)
2007 9	Molecular diagnosis of leishmaniasis: current status and future applications. [17093038] J Clin Microbiol 45(1): 21-5 (2007)
2001 10	HIV-associated visceral leishmaniasis. [11442562] Clin Microbiol Infect 7(6): 291-300 (2001)
2006 11	Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. [16323101] Clin Infect Dis 42(1): 115-25 (2006)
2007 12	Treatment of mucosal leishmaniasis in Latin America: systematic review. [17690398] Am J Trop Med Hyg 77(2): 266-74 (2007)
2004 13	Treatment of visceral leishmaniasis in 2004. [15642973] Am J Trop Med Hyg 71(6): 787-94 (2004)
2006 14	Immunology of canine leishmaniasis. [16842269] Parasite Immunol 28(7): 329-37 (2006)
2008 15	The Leishmania-macrophage interaction: a metabolic perspective. [18070117] Cell Microbiol 10(2): 301-8 (2008)
2007 16	Molecular mechanisms of antimony resistance in Leishmania. [17244793] J Med Microbiol 56(Pt 2): 143-53 (2007)
2008 17	Toll-like receptors and leishmaniasis. [18070909] Infect Immun 76(3): 866-72 (2008)
2002 18	Laboratory diagnosis of visceral leishmaniasis. [12204943] Clin Diagn Lab Immunol 9(5): 951-8 (2002)
2003 19	Recent understanding in the treatment of visceral leishmaniasis. [12865573] J Postgrad Med 49(1): 61-8 (2003)
2003 20	Recent advances in the diagnosis of leishmaniasis. [12865572] J Postgrad Med 49(1): 55-60 (2003)
2003 21	Cutaneous leishmaniasis: an overview. [12865571] J Postgrad Med 49(1): 50-4 (2003)
2003 22	Leishmaniasis in HIV infection. [12865570] J Postgrad Med 49(1): 39-49 (2003)
2003 23	An overview of paediatric leishmaniasis. [12865569] J Postgrad Med 49(1): 31-8 (2003)
2006 24	Leishmaniasis. [17068275] Postgrad Med J 82(972): 649-57 (2006)
2004 25	Immunity and immunosuppression in experimental visceral leishmaniasis. [15064826] Braz J Med Biol Res 37(4): 615-23 (2004)
2006 26	Animal models for vaccine studies for visceral leishmaniasis. [16778322] Indian J Med Res 123(3): 439-54 (2006)
2006 27	Current scenario of drug development for leishmaniasis. [16778319] Indian J Med Res 123(3): 399-410 (2006)
2006 28	Drug unresponsiveness & combination therapy for kala-azar. [16778318] Indian J Med Res 123(3): 389-98 (2006)
2006 29	Childhood visceral leishmaniasis. [16778316] Indian J Med Res 123(3): 353-6 (2006)
2006 30	Visceral leishmaniasis - current therapeutic modalities. [16778315] Indian J Med Res 123(3): 345-52 (2006)
2006 31	Visceral leishmaniasis (kala-azar): challenges ahead. [16778314] Indian J Med Res 123(3): 331-44 (2006)
2006 32	New developments in diagnosis of leishmaniasis. [16778313] Indian J Med Res 123(3): 311-30 (2006)
2006 33	Challenges in the diagnosis of post kala-azar dermal leishmaniasis. [16778312] Indian J Med Res 123(3): 295-310 (2006)
2006 34	Visceral leishmaniasis in the New World & Africa. [16778311] Indian J Med Res 123(3): 289-94 (2006)
2006 35	The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control. [16778310] Indian J Med Res 123(3): 275-88 (2006)
2006 36	Pathophysiology of visceral leishmaniasis - some recent concepts. [16778309] Indian J Med Res 123(3): 267-74 (2006)
2006 37	Immune responses in kala-azar. [16778308] Indian J Med Res 123(3): 245-66 (2006)
2006 38	Apoptosis in Leishmania species & its relevance to disease pathogenesis. [16778307] Indian J Med Res 123(3): 233-44 (2006)
2006 39	Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics. [16778306] Indian J Med Res 123(3): 221-32 (2006)
2006 40	Glycobiology of Leishmania donovani. [16778305] Indian J Med Res 123(3): 203-20 (2006)
2004 41	Immune response to Leishmania infection. [15243162] Indian J Med Res 119(6): 238-58 (2004)
2010 42	Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis. [21036832] Am J Trop Med Hyg 83(5): 1028-33 (2010)
2009 43	Leishmaniases in Bolivia: comprehensive review and current status. [19407110] Am J Trop Med Hyg 80(5): 704-11 (2009)
2010 44	Drug resistance in visceral leishmaniasis. [19888437] J Biomed Biotechnol 2010(-): 617521 (2010)
2010 45	The prominent role of neutrophils during the initial phase of infection by Leishmania parasites. [19884987] J Biomed Biotechnol 2010(-): 719361 (2010)
2011 46	Methylglyoxal metabolism in trypanosomes and leishmania. [21310261] Semin Cell Dev Biol 22(3): 271-7 (2011)
2008 47	Leishmania sand fly interaction: progress and challenges. [18625337] Curr Opin Microbiol 11(4): 340-4 (2008)
2009 48	Current status and perspectives of the immunotherapy of leishmaniasis. [20077951] Isr Med Assoc J 11(10): 623-8 (2009)
2007 49	Localized Leishmaniasis of the oral mucosa. A report of three cases. [17664913] Med Oral Patol Oral Cir Bucal 12(4): E281-6 (2007)
2003 50	Leishmanial infection: analysis of its first steps. A review. [14762510] Mem Inst Oswaldo Cruz 98(7): 861-70 (2003)
2004 51	Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. [15273794] Mem Inst Oswaldo Cruz 99(3): 239-51 (2004)
2007 52	Lutzomyia (Nyssomyia) whitmani s.l . (Antunes & Coutinho, 1939)(Diptera: Psychodidae: Phlebotominae): geographical distribution and the epidemiology of American cutaneous leishmaniasis in Brazil--mini-review. [17426877] Mem Inst Oswaldo Cruz 102(2): 149-53 (2007)
2007 53	Lutzomyia longipalpis in Brazil: a complex or a single species? A mini-review. [17293992] Mem Inst Oswaldo Cruz 102(1): 1-12 (2007)
2009 54	Proven and putative vectors of American cutaneous leishmaniasis in Brazil: aspects of their biology and vectorial competence. [20027458] Mem Inst Oswaldo Cruz 104(7): 937-54 (2009)
2010 55	Immunomodulators: use in combined therapy against leishmaniasis. [20586558] Expert Rev Anti Infect Ther 8(7): 739-42 (2010)
2010 56	Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. [20377337] Expert Rev Anti Infect Ther 8(4): 419-33 (2010)
2009 57	Perpetuation of Leishmania: some novel insight into elegant developmental programs. [19379663] Vet Res 40(2): 38 (2009)
2005 58	Management of visceral leishmaniasis: Indian perspective. [16519257] J Postgrad Med 51 Suppl 1(-): S53-7 (2005)
2010 59	Leishmaniasis emergence in Europe. [20403308] Euro Surveill 15(10): 19505 (2010)
2010 60	Protease inhibitors as prophylaxis against leishmaniasis: new hope from the major surface protease gp63. [21426002] Future Med Chem 2(4): 539-42 (2010)
2011 61	Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review. [21738967] An Bras Dermatol 86(3): 497-506 (2011)
2011 62	Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review. [21666786] PLoS Negl Trop Dis 5(6): e1153 (2011)
2008 63	Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis. [18725797] Curr Opin Infect Dis 21(5): 483-8 (2008)
2011 64	Structures, targets and recent approaches in anti-leishmanial drug discovery and development. [21629509] Open Med Chem J 5(-): 31-9 (2011)
2009 65	Control of phlebotomine (Diptera: Psychodidae) leishmaniasis vectors. [19618043] Neotrop Entomol 38(3): 303-10 (2009)
2010 66	Drug targets in Leishmania. [21526026] J Parasit Dis 34(1): 1-13 (2010)
2009 67	Leishmaniasis, an emerging disease found in companion animals in the United States. [19945086] Top Companion Anim Med 24(4): 182-8 (2009)
2011 68	Role of Co-stimulation in Leishmaniasis. [22110389] Int J Biol Sci 7(9): 1382-90 (2011)
2010 69	Morphological findings in bone marrow biopsy and aspirate smears of visceral Kala Azar: a review. [20090232] Indian J Pathol Microbiol 53(1): 96-100 (2010)
2008 70	Insect vectors of Leishmania: distribution, physiology and their control. [19248652] J Vector Borne Dis 45(4): 255-72 (2008)
2011 71	Role of heme and heme-proteins in trypanosomatid essential metabolic pathways. [21603276] Enzyme Res 2011(-): 873230 (2011)
2010 72	A current perspective on leishmaniasis. [20606967] J Glob Infect Dis 2(2): 124-6 (2010)
2010 73	The biology and control of leishmaniasis vectors. [20606968] J Glob Infect Dis 2(2): 127-34 (2010)
2010 74	Immunological perspectives of leishmaniasis. [20606969] J Glob Infect Dis 2(2): 135-46 (2010)
2010 75	Treatment of visceral leishmaniasis. [20606971] J Glob Infect Dis 2(2): 151-8 (2010)
2010 76	Leishmaniasis Vaccine: Where are We Today? [20606974] J Glob Infect Dis 2(2): 177-85 (2010)
2011 77	How effective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy. [21468480] Rev Soc Bras Med Trop 44(2): 232-42 (2011)
2007 78	An insight into the Leishmania RNA virus. [17377345] Indian J Med Microbiol 25(1): 7-9 (2007)
2011 79	One health: the importance of companion animal vector-borne diseases. [21489237] Parasit Vectors 4(-): 49 (2011)
2010 80	Phospholipid and sphingolipid metabolism in Leishmania. [20026359] Mol Biochem Parasitol 170(2): 55-64 (2010)
2007 81	Short communication: post-kala-azar dermal leishmaniasis--an appraisal. [17596251] Trop Med Int Health 12(7): 848-51 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leishmaniasis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leishmaniasis.php on line 92